You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-malarials

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus Trial in United States (Hydroxychloroquine, Placebo Oral Capsule)

Recruiting
  • Systemic Lupus Erythematosus
  • Los Angeles, California
  • +6 more
Oct 29, 2021

Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis Trial in Edmonton (Hydroxychloroquine/Chloroquine)

Active, not recruiting
  • Covid-19 Infection
  • +3 more
  • Hydroxychloroquine/Chloroquine
  • Edmonton, Alberta, Canada
    University of Alberta
Jul 19, 2022

Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

Terminated
  • Serologically Active Adult Systemic Lupus Erythematosus
  • Autologous EBV specific CTL infusion
  • Nantes, France
  • +2 more
Mar 24, 2022

Malaria Trial in Manhiça (Rosiglitazone, Placebo)

Unknown status
  • Malaria
  • Manhiça, Maputo, Mozambique
    Centro de Investigação em Saude da Manhiça
Jan 26, 2021

Sarcoidosis, Cutaneous Sarcoidosis Trial in Stanford (Humira)

Withdrawn
  • Sarcoidosis
  • Cutaneous Sarcoidosis
  • Stanford, California
    Stanford University
Feb 3, 2022

Systemic Lupus Erythematosus Trial in China (Telitacicept, standard therapy)

Recruiting
  • Systemic Lupus Erythematosus
  • Telitacicept
  • standard therapy
  • Bengbu, Anhui, China
  • +18 more
May 22, 2022

Systemic Lupus Erythematosus Trial in Worldwide (BENLYSTA, SLE treatment)

Active, not recruiting
  • Systemic Lupus Erythematosus
  • BENLYSTA
  • SLE treatment
  • Birmingham, Alabama
  • +177 more
Jan 23, 2023

Malaria,Falciparum, Child, Only Trial in Ouagadougou, Bamako (Tetanus/diphtheria toxoids, SMC with SP+AQ, RTS,S/AS01)

Active, not recruiting
  • Malaria,Falciparum
  • Child, Only
  • Tetanus/diphtheria toxoids
  • +3 more
  • Ouagadougou, Direction Régionale De l'Ouest, Burkina Faso
  • +1 more
Sep 6, 2021

Discoid Lupus Erythematosus Trial in New York (CC-10004)

Completed
Has Results
  • Discoid Lupus Erythematosus
  • New York, New York
    New York University Tisch Hospital
Feb 10, 2021

Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)

Active, not recruiting
  • Plasmodium Falciparum
  • RTS,S/AS01E
  • Abhayrab rabies vaccine
  • Kisumu, Kisumu County, Kenya
    Kombewa Clinical Research Center
Oct 7, 2021

Systemic Lupus Erythematosus Trial in Worldwide (Belimumab, Rituximab, Rituximab-)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Birmingham, Alabama
  • +78 more
Mar 25, 2022

Malaria,Falciparum, Children, Only Trial in Ouagadougou, Bamako (RABIPUR®, RTS,S/AS01, SMC with SP+AQ)

Completed
Has Results
  • Malaria,Falciparum
  • Children, Only
  • RABIPUR®
  • +3 more
  • Ouagadougou, Burkina Faso
  • +1 more
Mar 14, 2022

Diagnostic Score for Encephalitis to Assess Risk of Autoimmune

Recruiting
  • Autoimmune Encephalitis
  • Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
  • Clinical score of Granillo and al.
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

Technology Trial in Hong Kong (The anti-wandering system)

Not yet recruiting
  • Technology
  • The anti-wandering system
  • Hong Kong, Hong Kong
    Haven of Hope Residential Service for the Disabled
Mar 28, 2023

NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel

Recruiting
  • Non-small Cell Lung Cancer
  • TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
  • TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
  • Beijing, Beijing, China
  • +2 more
Jun 19, 2023

Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

Recruiting
  • Seasonal Allergic Rhinitis
  • LP-003 dose 1
  • +2 more
  • Beijing, Beijing, China
  • +16 more
Sep 18, 2023

Celiac Disease Trial in Spain

Recruiting
  • Celiac Disease
    • Terrassa, Barcelona, Spain
    • +5 more
    Aug 10, 2023

    Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)

    Not yet recruiting
    • Thyroid Diseases
    • +2 more
    • curcumin
    • Anti-inflammatory diet
    • Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of
      Golbon Sohrab
    Jul 27, 2023

    T- and B-Cell Subpopulations in Membranous Nephropathy

    Recruiting
    • Membranous Nephropathy
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 31, 2023

      Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)

      Recruiting
      • Post-endodontic Pain
      • Cryotherapy
      • +2 more
      • Cairo, Egypt
        Ain Shams University
      Oct 13, 2023

      Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

      Not yet recruiting
      • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
      • +2 more
      • Biopsy
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 28, 2023

      Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

      Not yet recruiting
      • Refractory Cancer
      • +3 more
      • IMA402 (Phase Ia)
      • +2 more
      • Heidelberg, Baden-Wuerttemberg, Germany
      • +12 more
      Jul 14, 2023

      HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

      Recruiting
      • HER2-positive Gastric Cancer
      • Immunotherapy
      • Disitamab Vedotin combined with fruquintinib and Tislelizumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2023

      Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 5, 2023